Korro Bio
KRRO
49 hedge funds and large institutions have $619M invested in Korro Bio in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 2 closing their positions.
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
105% more capital invested
Capital invested by funds: $302M → $619M (+$317M)
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
23% more funds holding
Funds holding: 40 → 49 (+9)
4.13% more ownership
Funds ownership: 82.03% → 86.16% (+4.1%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $9K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Verition Fund Management
Greenwich,
Connecticut
|
+$4.48M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$3.95M |
| 3 |
Millennium Management
New York
|
+$3.32M |
| 4 |
Goldman Sachs
New York
|
+$2.47M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$1.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.93M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$482K |
| 3 |
BlackRock
New York
|
-$273K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$235K |
| 5 |
Morgan Stanley
New York
|
-$233K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Group One Trading
Chicago,
Illinois
| – | -$218 | -4 | Closed |
|
KRRO Hedge Fund Activity: Q1 2024 in Review
49 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q1 2024, worth a combined $619M — up 105% from $302M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new KRRO positions and 2 closed out — a net gain of 9 holders — while 12 added to existing stakes and 9 trimmed.
The largest buyer was Verition Fund Management, adding an estimated $4.48M. The largest seller was Monashee Investment Management, cutting an estimated $1.93M.
- 49 institutional investors held Korro Bio (KRRO) as of Q1 2024, up from 40 in Q4 2023.
- Funds reported $619M of Korro Bio stock for Q1 2024, up 105% quarter-over-quarter.
- 11 funds opened new Korro Bio positions in Q1 2024 and 2 closed out, a net change of +9 holders.
- The largest Korro Bio buyer in Q1 2024 was Verition Fund Management, an estimated $4.48M added.
- The largest Korro Bio seller in Q1 2024 was Monashee Investment Management, an estimated $1.93M sold.
Based on aggregated 13F filings for Q1 2024.